Abstract
Stem cells play an essential role in cellular specialization and pattern formation during embryogenesis and in tissue regeneration in adults. This is mainly due to a stem cell's ability to replenish itself (self-renewal) and, at the same time, produce differentiated progeny. Realization of these special stem cell features has changed the prospective of the field. However, regulation of stem cell self-renewal and maintenance of its potentiality require a complicated regulatory network of both extracellular cues and intrinsic programs. Understanding how signaling regulates stem cell behavior will shed light on the molecular mechanisms underlying stem cell self-renewal. In this review, we focus on comparing the progress of recent research regarding the roles of the BMP signaling pathway in different stem cell systems, including embryonic stem cells, germline stem cells, hematopoietic stem cells, and intestinal stem cells. We hope this comparison, together with a brief look at other signaling pathways, will bring a more balanced view of BMP signaling in regulation of stem cell properties, and further point to a general principle that self-renewal of stem cells may require a combination of maintenance of proliferation potential, inhibition of apoptosis, and blocking of differentiation.
Stem cells are the key subset of cells functioning as ancestor cells to produce a variety of types of functionally specialized mature cells in a given tissue, while at the same time undergoing self-renewal, a process of reproducing themselves without losing their developmental potentiality. This self-renewal process is controlled by intrinsic genetic pathways that are subject to regulation by extrinsic signals from the microenvironment (called niche) in which stem cells reside. Stem cells play essential roles ranging from embryonic development and organogenesis (embryonic/fetal stem cells) to tissue regeneration (adult stem cells) (Lin, 2003, Spradling et al., 2001, Watt and Hogan, 2000andWeissman, 2000). To maintain homeostasis, a precise balance between self-renewal and differentiation of stem cells is essential. Loss of this balance tends to lead to uncontrolled cell growth or pre-maturation and thus results in tumors, cancers, or tissue defects. Therefore, understanding the complex signal regulation of stem cell development is crucial for future therapeutic applications. In this review, we will focus on progress that has been made in research studying the bone morphogenesis protein (BMP) signaling pathway in regulation of stem cell properties.
BMPs belong to the transformation growth factor beta (TGF) superfamily. They are involved in regulation of cell proliferation, differentiation, and apoptosis and therefore play essential roles during embryonic development and pattern formation ( Massague, 1998). To maintain homeostasis in adults, the BMP signal also participates in tissue remodeling and regeneration, in which regulation of stem cell behavior is prominent.
There are more than 20 BMPs. Some BMPs have a distinct function while others have overlapping functions, depending on the specificity of their interaction with different types of receptors and the tissues in which they are differentially expressed (Mishina, 2003). Accumulated evidence indicates that BMPs play an important role in regulation of stem cell properties; however, their functions are different in the different stem cell compartments. For instance, in Drosophila germline stem cells (GSCs), Dpp (homolog of BMP2/4) is essential for the maintenance of stem cells ( Xie and Spradling, 1998); in embryonic stem cells (ESCs), BMP signaling appears to be required for ESC self-renewal but this is owing to its ability to block neural differentiation ( Ying et al., 2003a) in addition to its ability to promote non-neural (mesoderm and trophoblast) differentiation ( Xu et al., 2002andYing et al., 2003a); in mesenchymal stem cells, the BMP signal induces osteoblastic differentiation through Bmpr1b but inhibits osteoblastic differentiation through Bmpr1a (Chen et al., 1998); in intestinal stem cells (ISCs), BMP signaling inhibits stem cell activation and expansion (He et al., 2004); and in hematopoietic stem cells (HSCs), BMP signaling through Bmpr1a restricts stem cell number by controlling the niche size (Zhang et al., 2003). A critical and comparative review of the roles of BMPs in different settings and in different stem cell compartments is necessary for a balanced view towards BMP function in the regulation of stem cell properties, and thus will provide important insight into understanding the complex signaling regulation of stem cell self-renewal and fate determination.
The molecular mechanisms that control stem cell self-renewal remain largely unknown, albeit a large body of literature has been published with regard to stem cell self-renewal and the related signaling pathways. In the literature, self-renewal is generally described as a parallel cellular event of proliferation, differentiation, and apoptosis. However, accumulated evidence suggests that self-renewal of stem cells requires a combination of events: maintenance of their proliferation potential, inhibition of apoptosis, and blocking of differentiation.
Multiple signaling pathways have been reported to contribute to the regulation of stem cell self-renewal. However, different molecules and the underlying pathways may play different and overlapping roles in this regard. Maintaining proliferation potential is an obvious principle required for self-renewal of stem cells. However, it is worthwhile to point out that proliferation potential (defined as the capacity of stem cells to undergo continuous division) is different from proliferation per se in that the more the stem cells undergo active proliferation, the more they tend to lose their potential for proliferation. Therefore, stem cell proliferation potential is a functional property which can only be measured by continuous in vitro cell culture, or in vivo repopulation functional assay, rather than by measurement of the rate of proliferation. Recently, several lines of evidence have suggested that the Wnt signaling pathway through -catenin is important for self-renewal of HSCs (Austin et al., 1997, Brandon et al., 2000, Murdoch et al., 2003, Reya et al., 2003, Van Den Berg et al., 1998andWillert et al., 2003), hair follicle stem cells (DasGupta and Fuchs, 1999, Gat et al., 1998andHuelsken et al., 2001), ISCs (He et al., 2004, Sancho et al., 2003andSancho et al., 2004), and ESCs (Sato et al., 2004). In addition to its function in lineage fate determination, the prominent role of Wnt signaling favors cell proliferation and promotes cell growth. Abnormal activation of -catenin leads to over-proliferation of stem cells and results in tumors in the intestines and in hair follicles (Gat et al., 1998andSancho et al., 2004). In contrast, deletion of a Wnt downstream factor, Tcf4, leads to loss of stem cells in the intestines (Korinek et al., 1998). These observations suggest that Wnt/-catenin signaling is important for the proliferation potential of stem cells as -catenin may stimulate Tert (encoding the catalytic subunit of telomerase) expression via activation of Myc (He et al., 1998, Wang et al., 1998andZou et al., 2005). The idea that limiting the proliferation potential affects stem cell self-renewal has been well demonstrated by studies of telomerase (Morrison et al., 1996), HoxB4 (Antonchuk et al., 2002, Helgason et al., 1996, Kyba et al., 2002andSauvageau et al., 1995), p18 (Yuan et al., 2004), P21(Cheng et al., 2000), and Bmi (Lessard and Sauvageau, 2003, Molofsky et al., 2003andPark et al., 2003).
Recent reports indicate that suppression of apoptosis plays an essential role in stem cell self-renewal (Domen and Weissman, 2000, Domen et al., 2000, Opferman et al., 2005andYamane et al., 2005). This idea is further enforced by the fact that the role of -catenin in promoting HSC self-renewal is prominent in the Bcl2-transgenic mouse (Reya et al., 2003), indicating that a coordination between Bcl2, which inhibits apoptosis, and -catenin, which is important for proliferation potential, is required for stem cell self-renewal. Likewise, transgenic expression of the activated form of -catenin alone tends to lead to crypt cell apoptosis, as shown in the intestinal system (Wong et al., 1998). It is also reported that Akt is activated during intestinal stem cell activation and division (He et al., 2004), as well as during hair follicle stem cell activation (Zhang and Li manuscript, submitted). As Akt is a cell survival factor in general, activation of Akt during stem cell activation and division may be necessary to protect stem cells from apoptotic stress including that from partial anoikis, a phenomenon caused by detachment from the extracellular matrix during cell division (Khwaja et al., 1997). Consistent with this conclusion, activation of PI3K/Akt, as a consequence of the loss of PTEN-function, has been reported to result in expansion of embryonic and neural stem cell populations (Groszer et al., 2001andKimura et al., 2003).
More here:
BMP signaling and stem cell regulation - ScienceDirect
- BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K) - Marketscreener.com - March 29th, 2023
- Induced Pluripotent Stem Cell for the Study and Treatment of ... - Hindawi - December 3rd, 2022
- What Happens When Everyone Realises We Can Live Much Longer? We May Find Out As Soon As 2025 - Forbes - December 3rd, 2022
- INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - November 17th, 2022
- 3D Cell Culture Market stands at revenue of US$ 1.15 Bn in 2022, and is predicted to surge at a CAGR of 9.8% to hit worth of US$ 2.67 Bn during... - November 17th, 2022
- YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - November 17th, 2022
- ACTINIUM PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-Q) - Marketscreener.com - November 17th, 2022
- Top 10 Best Stem Cell Supplement Brands - Healthtrends - June 26th, 2022
- How Does Stem Cell Therapy Work and What Are the Risks? | ISCRM - June 26th, 2022
- Stem Cell Wellness Kit - June 26th, 2022
- Kangstem Biotech withdraws trial application for stem cell-based osteoarthritis treatment - KBR - June 26th, 2022
- Global Human Embryonic Stem Cell Market to be Driven by the Rapid Technological Advancements in the Forecast Period of 2022-2027 Designer Women -... - June 26th, 2022
- Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the... - June 26th, 2022
- Efficient terminal erythroid differentiation requires the APC/C cofactor Cdh1 to limit replicative stress in erythroblasts | Scientific Reports -... - June 26th, 2022
- Propanc Biopharma's CSO Hails Dostarlimab's Impressive Results Whilst Acknowledging More Work to Be Done in the Fight Against Cancer - Business Wire - June 26th, 2022
- Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including... - June 26th, 2022
- 10 Years of Immunotherapy: Advances, Innovations, and Better Patient Outcomes - Targeted Oncology - June 26th, 2022
- Embryonic Stem Cell Research: An Ethical Dilemma - January 30th, 2022
- Skeletal Muscle Cell Induction from Pluripotent Stem Cells - January 30th, 2022
- mRNA COVID-19 Vaccine Effectiveness in the Immunocompromised - Medscape - January 30th, 2022
- MaaT Pharma Announces Positive Interim Engraftment Data for Oral Formulation MaaT033 Allowing Early Termination of Phase 1b CIMON Study - Business... - January 30th, 2022
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following... - January 30th, 2022
- Targeted Therapy Innovator Foresees New Paradigms in Breast Cancer - OncLive - January 30th, 2022
- Global Circulating Tumor Cells (CTC) Market Growing Demand, Future Trends, Competitive Regions and Forecast 2021 to 2027 The Oxford Spokesman - The... - January 30th, 2022
- Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |... - December 8th, 2021
- All at-risk TN-bound travellers test Covid negative - The New Indian Express - December 8th, 2021
- Good Stocks To Invest In Right Now? 4 Health Care Stocks To Check Out - FW Business - December 8th, 2021
- Pandemic lockdown declined emotional well-being for adults with hearing, vision loss: Study - ETHealthworld.com - December 8th, 2021
- Impact of microbial contamination of haematopoietic stem cells on post-transplant outcomes: A retrospective study from tertiary care centre in India -... - August 17th, 2021
- Longeveron: Time to Buy the Di - GuruFocus.com - August 17th, 2021
- The latest on the Covid-19 pandemic in the US: Live updates - CNN - August 17th, 2021
- How this Holocaust refugee beat Covid-19 against all odds J. - The Jewish News of Northern California - August 17th, 2021
- Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling -... - August 17th, 2021
- Oklahoma 10-year-old in remission after being diagnosed with rare form of leukemia 2 years ago - KFOR Oklahoma City - July 21st, 2021
- Covid: There's a serious problem with how we are testing people for the virus Neale Hanvey MP - The Scotsman - July 21st, 2021
- Profilin 1 Protein and Its Implications for Cancers - Cancer Network - July 21st, 2021
- Homing Technology Delivers Therapy to Cancerous Bone - The Scientist - July 21st, 2021
- Developmental Interest in Allogeneic PlacentaDerived Cell Therapies Expands - OncLive - July 21st, 2021
- Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches - DocWire News - July 21st, 2021
- The World's First Lab-Grown Foie Gras Could Solve This Major Concern - Mashed - July 21st, 2021
- KEYTRUDA (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Showed Statistically Significant Event-Free... - July 21st, 2021
- Human Mesenchymal Stem Cells (hMSC) Market Size 2021 | Global Trends, Business Overview, Challenges, Opportunities and Forecast to 2027 The Bisouv... - March 3rd, 2021
- [Full text] An Update on the Molecular Pathology of Metaplastic Breast Cancer | BCTT - Dove Medical Press - March 3rd, 2021
- 4D Pharma Appointments Paul Maier to the Board as Non-Executive Director - Business Wire - March 3rd, 2021
- Investigative Interventions Gain Ground in GVHD - OncLive - March 3rd, 2021
- Combination Regimens for Multiple Myeloma Show Efficacy in the Transplant-Ineligible Population, According to Dingli - Targeted Oncology - March 3rd, 2021
- Martin Makes Sense of the Rapidly Evolving MCL Treatment Paradigm - OncLive - March 3rd, 2021
- Hoth Therapeutics Expands License Agreement to Include Innovative Cancer and Anaphylactic Treatment - BioSpace - March 3rd, 2021
- Health Matters; Inflammation with Dr. Baumgartner [PODCAST] - WJON News - February 14th, 2021
- G1 Therapeutics gains first FDA nod with myelopreservation therapy Cosela | 2021-02-12 - BioWorld Online - February 14th, 2021
- Kris Gopalakrishnan on innovation - Fortune India - February 14th, 2021
- Change is coming, and at an ever-accelerating pace - Al Jazeera English - January 12th, 2021
- MCL Landscape Adapts to Changes After CAR T-Cell Therapy Approval - OncLive - January 9th, 2021
- 5 questions facing gene therapy in 2021 - BioPharma Dive - January 9th, 2021
- RNA molecules are masters of their own destiny - MIT News - January 9th, 2021
- Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market: Industry Analysis and Forecast (2019-2026): By indication type, treatment type,... - January 9th, 2021
- Harpoon Therapeutics : Clin Cancer Res 2021; OnlineFirst version Jan 6, 2021 - Marketscreener.com - January 9th, 2021
- Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity - Science Advances - January 5th, 2021
- Versiti Blood Centers and Noodles & Company Serve Up Thanks to Blood Donors - PRNewswire - January 5th, 2021
- January 2021: 2020 Papers of the Year - Environmental Factor Newsletter - January 5th, 2021
- Ozone in the air is bad for birds - Massive Science - January 5th, 2021
- How good are the COVID-19 vaccines? - Massive Science - January 5th, 2021
- Stem cells from cord blood can now be used across many conditions: Mayur Abhaya, MD & CEO, LifeCell Internat.. - ETHealthworld.com - December 28th, 2020
- Allogeneic SCT Benefits Children and Adolescents With Relapsed Anaplastic Large Cell Lymphoma - OncLive - December 28th, 2020
- CalvinAyre.com's most read life stories of 2020 - CalvinAyre.com - December 28th, 2020
- Coronavirus | Over 6,000 travellers from U.K. traced across States - The Hindu - December 28th, 2020
- Exosomes act as messengers and decoys to save healthy cells from viral infection - Massive Science - December 28th, 2020
- Celtics adjust to two-game series designed to reduce team travel - The Boston Globe - December 28th, 2020
- Experts Reflect on Most Impactful FDA Moves of 2020 in Solid Tumors, Hematologic Malignancies - Targeted Oncology - December 28th, 2020
- FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix (leronlimab) Following Full Enrollment in CytoDyn's Phase 3 Trial... - December 28th, 2020
- Magenta Therapeutics Announces Commencement of First Phase 2 Clinical Trial of MGTA-145 for Stem Cell Mobilization, Oral Presentation of MGTA-145... - December 12th, 2020
- Daratumumab Regimen Shows Promise in Transplant-Eligible Patients With Newly Diagnosed Myeloma - Targeted Oncology - December 12th, 2020
- HSCT Found Potentially Curative for Some T-Cell Lymphoma Patients - Cancer Therapy Advisor - December 12th, 2020
- Researchers Trace the Origin of Blood Cancer to Early Childhood, Decades before Diagnosis - Yahoo Finance - December 12th, 2020
- ALLO-715, Off-the-Shelf CAR T-Cell Therapy, Produces Early Promise in Multiple Myeloma - Cancer Network - December 12th, 2020
- BeiGene Announces the Approval in China of BLINCYTO (Blinatumomab) for Injection for Adult Patients with Relapsed or Refractory B-Cell Precursor Acute... - December 12th, 2020
- Flintshire youngster goes the extra mile to raise funds for Lymphoma Action | The Leader - LeaderLive - December 12th, 2020
- Meat-Tech Agrees to Acquire Cultured Fat Pioneer 'Peace of Meat' - PRNewswire - December 12th, 2020
- Stem Cell Manufacturing Market Size, Overview with Detailed Analysis, Competitive landscape, Forecast to 2027 - Cheshire Media - December 12th, 2020
- Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62nd American... - December 12th, 2020